Skip to main content
SpringerLink
Log in

Myostatinantikörper bei Einschlusskörpermyositis

Mehr Muskelmasse, aber keine Verbesserung der Muskelfunktion

  • journal club
  • Published:
InFo Neurologie & Psychiatrie Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  • Hanna MG, Badrisink UA, Benveniste O et al. Safety and efficacy of intravenous bimagrumab in inclusion body myositis (RESILIENT): a randomized, double-blind, placebo-controlled phase 2b trial. Lancet Neurol 2019; 18: 834–44

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Klinik und Poliklinik für Neurologie, Klinikum Carl Gustav Carus der TU Dresden, Dekan der Medizinischen Fakultät, Dresden, Deutschland

    Heinz Reichmann (Direktor)

Authors
  1. Heinz Reichmann
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Heinz Reichmann.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Reichmann, H. Mehr Muskelmasse, aber keine Verbesserung der Muskelfunktion. InFo Neurologie 21, 18–19 (2019). https://doi.org/10.1007/s15005-019-0205-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15005-019-0205-0

Search

Navigation